atopic dermatitis

Partner Content

Partner Content

Independent expert analysis of the pipeline in 5 disease are...

Leading dermatologists discuss the innovations shaping 5 chronic skin diseases—psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa—and share the challenges and

White Papers

Ensuring successful digital outreach and retention in atopic...

Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies.

News

Sidekick and Pfizer prep launch of DTx for atopic dermatitis

A long-running partnership between digital therapeutics (DTx) developer Si

News

Leo puts target on Dupixent in US as FDA clears tralokinumab

Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma's rival antibody tralokinumab.

News

Pharma group will develop 'digital endpoint' for atopic derm...

The development of digital medicine requires valid endpoints that can be used in clinical trials, and a consortium of pharma companies has just identified a new one for atopic dermatitis.

News